India has overtaken the US on clinical trials but struggles with regulation

BMJ 2026

View at publisher
Authors: Neha Bhatt
DOI: 10.1136/bmj.s219
Cited by: 1
References: 1

Abstract

India’s vast patient population and growing healthcare infrastructure has seen it overtake the US as a go-to for clinical trials. But unethical practices worry doctors as the sector expands, writes Neha Bhatt

Fields of Study & Subjects

Pharmaceutical industry and healthcare Biomedical Ethics and Regulation Science Research and Medicine

Publication details

Journal / source
BMJ
Publisher
BMJ
Volume
392
Pages
s219–s219
Publication date
13 February 2026
Language
EN